FARALLON CAPITAL MANAGEMENT LLC

Q1 2025 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
3/31/2025
Date filed
5/15/2025
Form type
13F-HR
Num holdings
135
Total value ($000)
$17,935,797
Net value change ($000)
-1,782,501 (-9.0%)
New positions
16
Sold out positions
13
Turnover %
9.3%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q4 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Intra-Cellular Therapies, Inc. 403,016 NEW
MSFT 169,709 24.7%
ARMK 134,954 31.7%
CRM 123,309 30.5%
LNTH 112,277 23.6%
BBIO 83,010 72.1%
SGI 79,415 NEW
VRNA 68,886 NEW
PTGX 66,437 29.0%
SCHW 65,498 27.9%
Top Reduces (Value $000, Stocks/ETFs)
ABNB -319,221 -100.0%
AON -279,907 -42.5%
SRPT -198,938 -57.1%
BMY -180,313 -100.0%
GOOGL -135,933 -34.3%
TMO -126,135 -19.7%
IBIT -113,887 -29.6%
RVMD -100,911 -17.4%
EDU -89,011 -58.8%
YMM -85,499 -47.6%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,306,427 (12.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type